Skip to main
ACOG

ACOG Stock Forecast & Price Target

ACOG Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Alpha Cognition is currently undervalued with a total enterprise value of $520M, assuming peak annual sales of $540M for ZUNVEYL in the US and employing a 12% discount rate and a 3% terminal rate of decline. There is potential for growth as the company focuses on increasing sales through differentiation, addressing key issues with current treatments, and seeking partnerships for additional indications and formulations. Risks include potential setbacks in clinical testing and slower market uptake of ZUNVEYL due to pricing pressures and competition, which could lead to medium to long-term dilution risk.

Bears say

Alpha Cognition is facing a negative outlook due to its limited commercial success with ZUNVEYL and ongoing clinical trials. Despite beating top and bottom-line expectations, the company's financials remain weak and it is projected to not reach profitability until 2027. The recent early settlement agreement to erase future royalty and milestone payments indicates potential financial struggles and the stock may continue to underperform.

ACOG has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alpha Cognition Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alpha Cognition Inc (ACOG) Forecast

Analysts have given ACOG a Strong Buy based on their latest research and market trends.

According to 3 analysts, ACOG has a Strong Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alpha Cognition Inc (ACOG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.